Holdings
Artia Global Partners LP
As of Jun 30, 2026, Artia Global Partners LP reported 41 positions worth US$456M. Largest: Abivax Sa, Insmed Incorporated and Trevi Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Abivax Sa | 516K | US$68.8M | −84,300 | Jun 30, 2026 |
| Insmed Incorporated | 589K | US$62.8M | −39,660 | Jun 30, 2026 |
| Trevi Therapeutics, Inc. | 2.21M | US$41.2M | +197K | Jun 30, 2026 |
| Brightspring Health Services, Inc. | 517K | US$36.1M | +464K | Jun 30, 2026 |
| Revolution Medicines, Inc. | 185K | US$34.7M | +60,400 | Jun 30, 2026 |
| Argenx Se | 29,739 | US$27.6M | no change | Jun 30, 2026 |
| Travere Therapeutics, Inc. | 339K | US$19.3M | +268K | Jun 30, 2026 |
| Dianthus Therapeutics, Inc. | 163K | US$15.9M | no change | Jun 30, 2026 |
| Quest Diagnostics Incorporated | 65,122 | US$13.8M | +24,305 | Jun 30, 2026 |
| Ionis Pharmaceuticals, Inc. | 144K | US$11.4M | no change | Jun 30, 2026 |